Karyopharm Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Company Progress
NEWTON, Mass., Feb. 11, 2021 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the fourth quarter and full year ended December 31, 2020. In addition, Karyopharm…
Comments Off on Karyopharm Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Company Progress